Document:

SECURITIES
        PURCHASE AGREEMENT

      

      
        	To:	
                PLASTINUM
                  POLYMER TECHNOLOGIES CORP. 

              

      

      245
        Park
        Avenue, 39th
        Floor

      New
        York,
        NY 10167

      USA

      Tel:
        + 1
        212 792 41 04

      Cell:
        +
        41 79 213 39 66

      Fax:
        + 41
        44 274 22 59

      

      Ladies
        and Gentlemen:

      

      The
        undersigned investor (the “Investor”), hereby confirms its agreement with you as
        follows:

      

      1. This
        Securities Purchase Agreement, including Annex I, and the exhibits thereto
        (the
“Agreement”) is made as of November 6, 2007 between Plastinum Polymer
        Technologies Corp.(the “Company”) and the Investor with respect to the sale of
        shares (the “Preferred Shares”) of the Company’s Series B-1 Convertible
        Preferred Stock (the “Series B-1 Preferred Stock”) and warrants to purchase
        shares of the Company’s Common Stock (the “Warrants”). The powers, designations,
        preferences and other rights of such of Series B-1 Preferred Stock are set
        forth
        on Exhibit A.

      

      2. The
        Company and the Investor agree that the Investor will purchase from the Company,
        and the Company will sell to the Investor, the number of Preferred Shares
        set
        forth opposite the Investor’s name on the signature page of this Agreement, at a
        purchase price per Preferred Share of $100, pursuant to the Terms and Conditions
        for Purchase of Securities attached hereto as Annex I and incorporated herein
        by
        reference as if fully set forth herein. Unless otherwise requested by the
        Investor, certificates representing the Preferred Shares and the Warrants
        will
        be registered in the Investor’s name and address as set forth
        below.

      

      The
        next
        page is the signature page.

      

      

        
          
            
            

          

          
            -1-

            
              

            

          

          
            
            

          

        

      

      Please
        confirm that the foregoing correctly sets forth the agreement between us
        by
        signing in the space provided below for that purpose.

      

      

      AGREED
        AND ACCEPTED:

      

      

      

      COMPANY: PLASTINUM
        POLYMER TECHNOLOGIES CORP.

      

       

      By:
         

      

      
 

      INVESTOR:   

      name
        of
        investor

      

      

      

      Number
        of
        Preferred Shares:  

       

      By:
         

      Signature
        of investor or authorized person

      

      

      Its:
         

      Title
        of
        authorized person

      

      

      Address:
         

      

       

      Contact
        Name:  

      Facsimile
        Number:  

      Email
        Address:  

      

      Name
        in
        which share certificates should be registered (if different):

      

      
 

      Social
        Security

      or
        Tax
        I.D. No:  

      

      

      Address
        where share certificates should be sent (if different):  

      
        
          
          

        

        
          -2-

          
            

          

        

        
          
          

        

      

      ANNEX
        I

      

      TERMS
        AND
        CONDITIONS FOR PURCHASE OF SECURITIES

      

      
        	1.	
                Authorization.
                  Subject to the terms and conditions in this Annex I, the Company
                  has
                  authorized the sale of up to 120,000 shares of Series B Convertible
                  Preferred Stock.

              

      

      

      
        	2.	
                Agreement
                  to Sell and Purchase the Preferred Shares and Warrants; Subscription;
                  Date.

              

      

      

      
        	2.1	
                At
                  the Closing (as defined in Section 2), the Company will sell to
                  the
                  Investor, and the Investor will purchase from the Company, upon
                  the terms
                  and conditions hereinafter set forth, the Preferred
                  Shares.

              

      

      

      
        	2.2	
                At
                  the Closing, the Company shall issue to Investor a warrant (the
“Warrant”)
                  to purchase such number of shares of the Company’s Common Stock
                  (“Conversion Shares”) equal to 30% of the shares issuable upon conversion
                  of the Preferred Shares at the initial conversion price thereof.
                  The
                  exercise price per Warrant Share for the Warrant shall equal $0.57.
                  The
                  Warrant shall not become exercisable until the first day after
                  the
                  expiration of six months after the Closing. The form of Warrant
                  is
                  attached hereto as Exhibit B. The Warrant and the Preferred Shares
                  are
                  collectively referred to herein as the
                  “Securities.”

              

      

      

      
        	2.3	
                The
                  Company is entering into a substantially similar form of Securities
                  Purchase Agreement, including these Terms and Conditions, with
                  the other
                  investors listed along with the Investor (the “Other Investors”). (The
                  Investor and the Other Investors are hereinafter sometimes collectively
                  referred to as the “Investors,” and the Securities Purchase Agreement to
                  which these Terms and Conditions are attached and the securities
                  purchase
                  agreements executed by the Other Investors are hereinafter sometimes
                  collectively referred to as the “Purchase
                  Agreements.”)

              

      

      

      
        	3.	
                Delivery
                  at Closing. The completion of the purchase and sale of the Securities
                  (the
                  “Closing”) shall occur no later than November 6, 2007 (the “Closing
                  Date”), at the offices of Westerman Ball Ederer Miller & Sharfstein
                  LLP, 170 Old Country Road, Mineola, NY 11501, USA, the Company’s counsel,
                  it being understood however, that additional Closings of the sale
                  of
                  Preferred Shares (“Additional Closings”) may occur from time to time
                  within 120 days of the initial Closing Date. At the Closing, the
                  Company
                  shall deliver to the Investor (i) one or more certificates representing,
                  in the aggregate, the Preferred Shares and the Warrant, each such
                  certificate to be registered in the name of the Investor or, if
                  so
                  indicated on the signature page of the Securities Purchase Agreement,
                  in
                  the name of a nominee designated by the Investor. If neither the
                  Investor
                  nor a representative of Investor is present at the Closing to take
                  physical delivery of the certificates, then delivery shall be deemed
                  made
                  at Closing by the transmission of a facsimile of the certificates
                  to the
                  Investor (or nominee designated by the Investor) followed by delivery
                  by a
                  nationally recognized overnight express
                  courier.

              

      

      

      
        The
          Company’s
          obligation to issue the Preferred Shares and Warrants to the Investor shall
          be
          subject to the following conditions, any one or more of which may be waived
          by
          the Company:

         

      

      
        
          
            	(a)	
                    receipt
                      by the Company, or the nominee designated by the Company, as
                      applicable,
                      of a certified or official bank check or wire transfer of funds
                      in the
                      full amount of the aggregate purchase price for the Preferred
                      Shares;

                  

          

        

      

       

      
        	(b)	
                other
                  than with respect to the occurrence of any Additional Closings,
                  completion
                  of the purchases and sales under the Agreements with the Other
                  Investors;
                  and

              

      

      
        
          
          

        

        
          -3-

          
            

          

        

        
          
          

        

      

      
        	(c)	
                the
                  accuracy of the representations and warranties made by the Investors
                  and
                  the fulfilment of those undertakings of the Investors to be fulfilled
                  prior to the Closing.

              

      

      

      The
        Investor’s obligation to purchase the Preferred Shares shall be subject to the
        following conditions, any one or more of which may be waived by the
        Investor:

      

      
        	(a)	
                the
                  representations and warranties of the Company set forth herein
                  shall be
                  true and complete as of the Closing Date in all material
                  respects;

              

      

      

      
        	(b)	
                the
                  Investor shall have received such documents as the Investor shall
                  reasonably have requested;

              

      

      

      
        	(c)	
                the
                  Company shall not have experienced a Material Adverse Change (as
                  defined
                  in paragraph 4.11);

              

      

      

      
        	(d)	
                the
                  Company shall have delivered to the Investor a certificate of its
                  Chief
                  Executive Officer dated as of the Closing Date certifying (i) that
                  the
                  representations and warranties of the Company remain true as of
                  the
                  Closing Date, (ii) that the Company has performed all covenants
                  in the
                  Agreements to be performed by it on or prior to Closing Date, (iii)
                  that
                  the Company has not experienced a Material Adverse Change, (iv)
                  that the
                  Common Stock has not been suspended from trading on the Over-the-Counter
                  Bulletin Board (“OTCBB”), and (v) that the Company is not subject to a
                  stop order of the Securities and Exchange Commission (the “SEC”) or any
                  state securities agency;

              

      

      

      
        	(e)	
                together
                  with the sale of Preferred Shares pursuant to this Agreement, the
                  Company
                  shall have received from Investors at least $1,750,000 from the
                  sale of
                  Preferred Shares; and

              

      

      

      
        	(f)	
                the
                  Company shall have executed and delivered a counterpart copy of
                  the
                  Registration Rights Agreement referred to in Section
                  7.1.

              

      

      

      At
        the
        Closing, if requested by a majority of the Investors as of the Closing Date,
        the
        Investors shall also receive a legal opinion from Westerman Ball Ederer Miller
        & Sharfstein, LLP, counsel to the Company, in form and substance to be
        provided.

      

      
        	4.	
                Representations,
                  Warranties and Covenants of the Company. The Company hereby represents
                  and
                  warrants to, and covenants with, the Investor, as
                  follows:

              

      

      

      
        	4.1	
                Subsidiaries;
                  Organization. All of the subsidiaries of the Company (the “Subsidiaries”)
                  are set forth on Schedule 4.1(a). Each of the Company and the Subsidiaries
                  is duly organized and validly existing and is in good standing
                  under the
                  laws of the jurisdiction of its organization. Each of the Company
                  and the
                  Subsidiaries has full power and authority to own, operate and occupy
                  its
                  properties and to conduct its business as presently conducted and
                  as
                  described in Company’s SEC Documents (as defined in paragraph 4.4), and is
                  registered or qualified to do business and is in good standing
                  in each
                  jurisdiction in which the failure to be so qualified would have
                  a material
                  adverse effect upon the business, condition (financial or otherwise),
                  business prospects, properties or operations of the Company and
                  its
                  Subsidiaries, considered as one enterprise (“Material Adverse Effect”),
                  and no proceeding has been instituted in any such jurisdiction,
                  revoking,
                  limiting or curtailing, or seeking to revoke, limit or curtail,
                  such power
                  and authority or qualification.

              

      

      

      
        
          	4.2	
                  Due
                    Authorization and Valid Issuance. The Company has all requisite
                    power and
                    authority to execute, deliver and perform its obligations under
                    the
                    Purchase Agreement, and the Registration Rights Agreement referred
                    to in
                    Section 7.1 (collectively, the “Transaction Documents”), and the
                    Agreements have been duly authorized and validly executed and
                    delivered by
                    the Company and constitute legal, valid and binding agreements
                    of the
                    Company enforceable against the Company in accordance
                    with their terms, except as enforceability may be limited by
                    applicable
                    bankruptcy, insolvency, reorganization, fraudulent conveyance,
                    moratorium
                    or similar laws affecting
                    creditors’

                

        

      

      
        
          
          

        

        
          -4-

          
            

          

        

        
          
          

        

      

      and
        contracting parties’ rights generally and except as enforceability may be
        subject to general principles of equity (regardless of whether such
        enforceability is considered in a proceeding in equity or at law).

      

      
        	4.3	
                Non-Contravention.
                  The execution and delivery of the Transaction Documents by the
                  Company,
                  the issuance and sale of the Preferred Shares and Warrants to be
                  sold by
                  the Company under the Agreements, the fulfilment of the terms of
                  the
                  Agreements by the Company and the consummation by the Company of
                  the
                  transactions contemplated hereby and thereby will not (A) conflict
                  with or
                  constitute a violation of, or default or require notice or consent
                  (with
                  the passage of time or otherwise) under (i) any material bond,
                  debenture,
                  note or other evidence of indebtedness, or under any material lease,
                  contract, indenture, mortgage, deed of trust, loan agreement, joint
                  venture or other agreement or instrument to which the Company or
                  any of
                  the Subsidiaries is a party or by which the Company or any of the
                  Subsidiaries or their respective properties are bound, (ii) the
                  charter,
                  by-laws or other organizational documents of the Company or any
                  of the
                  Subsidiaries, or (iii) any material law, administrative regulation,
                  ordinance or order of any court or governmental agency, arbitration
                  panel
                  or authority applicable to the Company or any of the Subsidiaries
                  or their
                  respective properties, or (B) result in the creation or imposition
                  of any
                  lien, encumbrance, claim, security interest or restriction whatsoever
                  upon
                  any of the material properties or assets of the Company or any
                  of the
                  Subsidiaries or an acceleration of indebtedness pursuant to any
                  obligation, agreement or condition contained in any material bond,
                  debenture, note or any other evidence of indebtedness or any material
                  indenture, mortgage, deed of trust or any other agreement or instrument
                  to
                  which the Company or any of the Subsidiaries is a party or by which
                  any of
                  them is bound or to which any of the property or assets of the
                  Company or
                  any of the Subsidiaries is subject. No consent, approval, authorization
                  or
                  other order of, or registration, qualification or filing with,
                  any
                  regulatory body, administrative agency, or other governmental body
                  in the
                  United States is required for the execution and delivery of the
                  Transaction Documents by the Company and the valid issuance and
                  sale of
                  the Preferred Shares to be sold by the Company pursuant to the
                  Agreements,
                  other than such as have been made or obtained, and except for any
                  post-closing securities filings or notifications required to be
                  made under
                  federal or state securities laws.

              

      

      

      
        	4.4	
                Reporting
                  Status. The Company has filed in a timely manner all documents
                  that the
                  Company was required to file under the Securities Exchange Act
                  of 1934, as
                  amended (the “Exchange Act”) during the 12 months preceding the date of
                  this Agreement, including all certifications and statements required
                  by
                  (x) 13a-14 or 15d-14 under the Exchange Act or (y) 18 USC 1350
                  (Section
                  906 of Sarbanes Oxley Act) (such filings, including all exhibits,
                  supplements and amendments thereto, the “SEC Documents”). The SEC
                  Documents and all other materials filed with the Securities and
                  Exchange
                  Commission (the “SEC”) during such period complied in all material
                  respects with the SEC’s requirements as of their respective filing dates,
                  and the information contained therein as of the dates thereof did
                  not
                  contain an untrue statement of a material fact or omit to state
                  a material
                  fact required to be stated therein or necessary to make the statements
                  therein in light of the circumstances under which they were made
                  not
                  misleading.

              

      

      

      
        	4.5	
                Capitalization.
                  The capitalization of the Company as of September 30, 2007 is as
                  set forth
                  on Schedule 4.5. All outstanding shares are duly authorized, validly
                  issued and are fully paid and nonassessable. None of the outstanding
                  shares has been offered or issued in violation of federal or state
                  securities laws, or in violation of or subject to any preemptive
                  rights or
                  other rights to subscribe for or purchase securities. The Company
                  has not
                  issued any capital stock since June 30, 2006 other than pursuant
                  to (i)
                  employee benefit plans disclosed in the SEC Documents, or (ii)
                  outstanding
                  warrants, options or other securities disclosed in the SEC Documents.
                  The
                  Preferred Shares to be issued on the date hereof, when issued in
                  compliance with the provisions of the Agreements, including without
                  limitation payment in full of the consideration therefor, will
                  be duly
                  authorized, and the Preferred Shares and the shares of the Common
                  Stock
                  issuable upon conversion of the Preferred Shares (the “Conversion Shares”)
                  when issued will be validly
                  issued,

              

      

      
        
          
          

        

        
          -5-

          
            

          

        

        
          
          

        

      

      fully
        paid and nonassessable, and will not subject the holder to any liability
        as a
        result of being a holder. Except as set forth on Schedule 4.5 or pursuant
        to the
        Purchase Agreements, there are no outstanding rights (including, without
        limitation, preemptive rights), warrants or options to acquire, or instruments
        convertible into or exchangeable for, any unissued shares of capital stock
        or
        other equity interest in the Company or the Subsidiaries, or any contract,
        commitment, agreement, understanding or arrangement of any kind to which
        the
        Company is a party or of which the Company has knowledge and relating to
        the
        issuance or sale of any capital stock of the Company or the Subsidiaries,
        any
        such convertible or exchangeable securities or any such rights, warrants
        or
        options. Without limiting the foregoing, no preemptive right, co-sale right,
        right of first refusal, registration right (except as set forth herein),
        or
        other similar right exists with respect to the Preferred Shares, the Warrants
        or
        the Company’s Common Stock to be issued and sold by the Company or the issuance
        and sale thereof. No further approval or authorization of any stockholder,
        the
        Board of Directors of the Company or others is required for the issuance
        and
        sale of the Preferred Shares, the Warrants or the Company’s Common Stock by the
        Company. There are no stockholders’ agreements, voting agreements or other
        similar agreements with respect to the Preferred Shares, the Warrants or
        the
        Company’s Common Stock to which the Company is a party or, to the knowledge of
        the Company, between or among any of the Company’s stockholders. Except as set
        forth on Schedule 4.5, no holder of any of the securities of the Company
        has any
        rights (“demand,” “piggyback” or otherwise) to have such securities registered
        by reason of the intention to file, filing or effectiveness of a Registration
        Statement (as defined in Section 7.1 hereof). The Company has duly reserved
        sufficient shares of Common Stock for issuance upon conversion of the Preferred
        Shares (the “Conversion Shares”) and the exercise of the Warrants (the “Warrant
        Shares”).

      

      
        	4.6	
                Legal
                  Proceedings. There is no material legal or governmental proceeding
                  pending
                  or, to the knowledge of the Company, threatened to which the Company
                  or
                  any of the Subsidiaries is or may be a party or of which the business
                  or
                  property of the Company or any of the Subsidiaries is subject.
                  There is no
                  action, suit, proceeding, inquiry or investigation before or by
                  any court,
                  public board or body (including, without limitation, the SEC) pending
                  or,
                  to the knowledge of the Company, threatened against or affecting
                  the
                  Company or the Subsidiaries or any of their respective business
                  or
                  properties, wherein an unfavorable decision, ruling or finding
                  could
                  adversely affect the validity or enforceability of, or the authority
                  or
                  ability of the Company to perform its obligations under the
                  Agreements.

              

      

      

      
        	4.7	
                No
                  Violations. Neither the Company nor any Subsidiary is in violation
                  of its
                  charter, bylaws, or other organizational document, or in violation
                  of any
                  material law, administrative regulation, ordinance or order of
                  any court
                  or governmental agency, arbitration panel or authority applicable
                  to the
                  Company or any Subsidiary, or in default or violation (and there
                  exists no
                  condition that, with the passage of time or otherwise, would constitute
                  a
                  default or violation) in any respect in the performance of any
                  material
                  bond, debenture, note or any other evidence of indebtedness in
                  any
                  indenture, mortgage, deed of trust or any other material agreement
                  or
                  instrument to which the Company or any Subsidiary is a party or
                  by which
                  the Company or any Subsidiary is bound or by which the properties
                  of the
                  Company or any Subsidiary are bound. Without limiting the generality
                  of
                  the foregoing, the Company is not in violation of any of the rules,
                  regulations or requirements of the OTCBB and has no knowledge of
                  any facts
                  or circumstances which would reasonably lead to suspension of the
                  Common
                  Stock by the OTCBB in the foreseeable
                  future.

              

      

      

      
        	4.8	
                Governmental
                  Permits, Etc. The Company and the Subsidiaries possess all necessary
                  franchises, licenses, certificates and other authorizations from
                  any
                  foreign, federal, state or local government or governmental agency,
                  department, or body that are currently necessary for the operation
                  of
                  their respective business as currently conducted, except where
                  the failure
                  to currently possess could not reasonably be expected to have a
                  Material
                  Adverse Effect.

              

      

      
        
          
          

        

        
          -6-

          
            

          

        

        
          
          

        

      

      
        	4.9	
                Intellectual
                  Property. The Company and the Subsidiaries own or possess sufficient
                  rights to use all patents, patent rights, trademarks, copyrights,
                  licenses, inventions, trade secrets, trade names and know-how
                  (collectively, “Intellectual Property”) that are necessary for the conduct
                  of their respective businesses as now conducted. Neither the Company
                  nor
                  any Subsidiary has received any notice of, or has any knowledge
                  of, any
                  infringement of asserted rights of a third party with respect to
                  any
                  Intellectual Property, and neither the Company nor any Subsidiary
                  has any
                  knowledge of any infringement by a third party with respect to
                  any
                  Intellectual Property of the Company or any
                  Subsidiary.

              

      

      

      
        	4.10	
                Financial
                  Statements. The consolidated financial statements of the Company
                  and the
                  related notes contained in the SEC Documents present fairly, in
                  accordance
                  with the rules and regulations of the SEC, the consolidated financial
                  position of the Company as of the dates indicated, and the results
                  of its
                  operations and cash flows for the periods therein specified. Such
                  financial statements (including the related notes) have been prepared
                  in
                  accordance with generally accepted accounting principles applied
                  on a
                  consistent basis throughout the periods therein specified, except
                  as set
                  forth in the financial statements (and the related
                  notes).

              

      

      

      
        	4.11	
                No
                  Material Adverse Change. Since January 1st,
                  2007 there has not been (i) any material adverse change in the
                  financial
                  condition or earnings of the Company and the Subsidiaries taken
                  as a
                  whole, nor has any material adverse event occurred with respect
                  to the
                  Company or the Subsidiaries, (ii) any obligation, direct or contingent,
                  that is material to the Company and the Subsidiaries taken as a
                  whole,
                  incurred by the Company or any Subsidiary, except obligations incurred
                  in
                  the ordinary course of business, (iii) any dividend or distribution
                  of any
                  kind declared, paid or made on the capital stock of the Company,
                  or (iv)
                  any loss or damage (whether or not insured) to the physical property
                  of
                  the Company or any Subsidiary which has been sustained which has
                  a
                  material adverse effect on the condition (financial or otherwise),
                  earnings, operations, business or business prospects of the Company
                  and
                  the Subsidiaries taken as a whole. Since January 1st,
                  2007, neither the Company nor any Subsidiary has (a) sold, assigned,
                  transferred, abandoned, mortgaged, pledged or subjected to lien
                  any of its
                  material properties, tangible or intangible, or rights under any
                  material
                  contract, permit, license, franchise or other agreement or (b)
                  waived or
                  cancelled any material indebtedness or other material obligations
                  owed to
                  the Company or such Subsidiary. The occurrence of any of the events
                  described in clauses (i) through (iv) and clauses (a) and (b) of
                  this
                  paragraph is referred to as a “Material Adverse
                  Change.”

              

      

      

      
        	4.12	
                No
                  Manipulation of Securities. The Company has not taken and will
                  not, in
                  violation of applicable law take, any action designed to or that
                  might
                  reasonably be expected to cause or result in stabilization or manipulation
                  of the price of the Common Stock to facilitate the sale or resale
                  of the
                  Preferred Shares.

              

      

      

      
        	4.13	
                OCTBB
                  Status. The Common Stock is traded on the OTCBB. The Company has
                  no reason
                  to believe that the Common Stock will be ineligible for quotation
                  on the
                  OTCBB.

              

      

      

      
        	4.14	
                Insurance.
                  The Company and the Subsidiaries maintain and will continue to
                  maintain
                  insurance against loss or damage by fire or other casualty and
                  such other
                  insurance, including, but not limited to, product liability insurance,
                  in
                  such amounts and covering such risks as is reasonably adequate
                  consistent
                  with industry practice for the conduct of their respective businesses
                  and
                  the value of their respective
                  properties.

              

      

      

      
        	4.15	
                Tax
                  Matters. The Company and the Subsidiaries have filed all material
                  federal,
                  state, local and foreign income and franchise and other tax returns
                  required to be filed by them in any jurisdiction to which they
                  are
                  subject, and have paid or accrued all taxes due in accordance therewith;
                  and no tax deficiency has been determined adversely to the Company
                  or any
                  Subsidiary which has had (nor does the Company or the Subsidiaries
                  have
                  any knowledge of any tax deficiency which,
                  if

              

      

      
        
          
          

        

        
          -7-

          
            

          

        

        
          
          

        

      

      determined
        adversely to the Company or any of the Subsidiaries, would reasonably be
        expected to have) a Material Adverse Effect.

      

      
        	4.16	
                Investment
                  Company. The Company is not an “investment company” within the meaning of
                  such term under the Investment Company Act of 1940 and the rules
                  and
                  regulations of the SEC thereunder.

              

      

      

      
        	4.17	
                No
                  Registration. No form of general solicitation or general advertising
                  was
                  used by the Company or, to the best of its knowledge, any other
                  Person
                  acting on behalf of the Company, in respect of the Preferred Shares
                  or in
                  connection with the offer and sale of the Preferred Shares. Assuming
                  the
                  accuracy of the representations and warranties made by, and compliance
                  with the covenants of, (i) the Investors in Section 5 of the Terms
                  and
                  Conditions to each of the Agreements, no registration of the Preferred
                  Shares under the Securities Act is required in connection with
                  the offer
                  and sale of the Preferred Shares by the Company to the Investors
                  as
                  contemplated by the Agreements.

              

      

      

      
        	4.18	
                Internal
                  Accounting Controls. The Company and the Subsidiaries maintain
                  a system of
                  internal accounting controls sufficient, in the judgment of the
                  Company’s
                  board of directors, to provide reasonable assurance that (i) transactions
                  are executed in accordance with management’s general or specific
                  authorizations, (ii) transactions are recorded as necessary to
                  permit
                  preparation of consolidated financial statements in conformity
                  with
                  generally accepted accounting principles and to maintain asset
                  accountability, (iii) access to assets is permitted only in accordance
                  with management’s general or specific authorization and (iv) the recorded
                  accountability for assets is compared with the existing assets
                  at
                  reasonable intervals and appropriate action is taken with respect
                  to any
                  differences. The Company has established disclosure controls and
                  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)
                  for
                  the Company and designed such disclosure controls and procedures
                  to ensure
                  that material information relating to the Company, is made known
                  to the
                  certifying officers by others within those entities, particularly
                  during
                  the period in which the Company’s Form 10-KSB or 10-QSB, as the case may
                  be, is being prepared. The Company’s certifying officers have evaluated
                  the effectiveness of the Company’s controls and procedures as of the end
                  of the period covered by the most recently filed Form 10-KSB (such
                  date,
                  the “Evaluation Date”). The Company presented in its most recently filed
                  Form 10-KSB the conclusions of the certifying officers about the
                  effectiveness of the disclosure controls and procedures based on
                  their
                  evaluations as of the Evaluation Date. Since the Evaluation Date,
                  there
                  have been no significant changes in the Company’s internal controls (as
                  such term is defined in Exchange Act Rules 13a-15(f) that has affected,
                  or
                  is reasonably likely to materially affect, the Company’s internal controls
                  over financial reporting.

              

      

      

      
        	4.19	
                Form
                  D. Subject to the continuing accuracy of the representations and
                  warranties made by, and compliance with the covenants of, the Investors
                  in
                  Section 5 of the Terms and Conditions to each of the Agreements
                  the
                  Company agrees to file one or more Form D with respect to the Preferred
                  Shares on a timely basis as required under Regulation D under the
                  Securities Act to claim the exemption provided by Rule 506 of Regulation
                  D
                  and to provide a copy thereof to the Investors and their counsel
                  promptly
                  after such filing.

              

      

      

      

      
        
          
            
            

          

          
            -8-

            
              

            

          

          
            
            

          

        

      

       

      
        	4.20	
                Integration
                  and Future Financings

              

      

      

      
        	
              	(a)	
                The
                  Company shall not, and shall use its best efforts to ensure that
                  no
                  affiliate of the Company shall, sell, offer for sale or solicit
                  offers to
                  buy or otherwise negotiate in respect of any security (as defined
                  in
                  Section 2 of the Securities Act) that would be integrated with
                  the
                  Offering in a manner that would require the registration of the
                  issuance
                  of the Preferred Shares under the Securities Act, or cause the
                  sale of the
                  Preferred Shares to the Investors to be integrated with prior offerings
                  by
                  the Company.

              

      

      

      
        	4.21	
                Use
                  of Proceeds. The Company will use the net proceeds from the sale
                  of the
                  Preferred Shares for working capital and general corporate purposes
                  and to
                  acquire capital equipment for expansion of production
                  capacity.

              

      

      

      
        	5.	
                Representations,
                  Warranties and Covenants of the
                  Investor.

              

      

      

      
        	5.1	
                The
                  Investor represents and warrants to, and covenants with, the Company
                  that:
                  (i) the Investor is an “accredited investor” as defined in Rule 501 of
                  Regulation D under the Securities Act , and the Investor is also
                  knowledgeable, sophisticated and experienced in making, and is
                  qualified
                  to make decisions with respect to, investments in securities presenting
                  an
                  investment decision like that involved in the purchase of the Preferred
                  Shares, including investments in securities issued by the Company
                  and
                  investments in comparable companies, and has requested, received,
                  reviewed
                  and considered all information it deemed relevant in making an
                  informed
                  decision to purchase the Preferred Shares; (ii) the Investor is
                  acquiring
                  the Preferred Shares in the ordinary course of its business and
                  for its
                  own account for investment only and with no present intention of
                  distributing any of such Preferred Shares or any arrangement or
                  understanding with any other persons regarding the distribution
                  of such
                  Preferred Shares; (iii) the Investor will not, directly or indirectly,
                  offer, sell, pledge, transfer or otherwise dispose of (or solicit
                  any
                  offers to buy, purchase or otherwise acquire or take a pledge of)
                  any of
                  the Preferred Shares except in compliance with the Securities Act,
                  applicable state securities laws and the respective rules and regulations
                  promulgated thereunder, except that the Investor may pledge the
                  Preferred
                  Shares in connection with a bona fide margin account or other loan
                  or
                  financing; (iv) the Investor and the Investor’s representatives, if any,
                  have been solely responsible for the Investor’s own “due diligence”
                  investigation of the Company and its management and business, for
                  its own
                  analysis of the merits and risks of this investment, and for the
                  Investor’s own analysis of the fairness and desirability of the terms of
                  the investment; and (v) the Investor has, in connection with its
                  decision
                  to purchase the Preferred Shares, relied only upon the SEC Documents
                  and
                  the representations and warranties of the Company contained herein.
                  The
                  Investor understands that its acquisition of the Preferred Shares
                  has not
                  been registered under the Securities Act or registered or qualified
                  under
                  any state securities law in reliance on specific exemptions therefrom,
                  which exemptions may depend upon, among other things, the bona
                  fide nature
                  of the Investor’s investment intent as expressed herein. The Investor has
                  completed or caused to be completed and delivered to the Company
                  the
                  Investor Questionnaire attached to this Annex I as Exhibit A, which
                  completed questionnaire is true, correct and complete in all material
                  respects.

              

      

      

      
        	5.2	
                The
                  Investor hereby covenants with the Company not to make any sale
                  of the
                  Shares or the Conversion Shares without complying with the provisions
                  of
                  this Agreement, and the Investor acknowledges that the certificates
                  evidencing the Preferred Shares and the Conversion Shares will
                  be
                  imprinted with a legend that prohibits their transfer except in
                  accordance
                  therewith.

              

      

      

      
        	5.3	
                The
                  Investor further represents and warrants to, and covenants with,
                  the
                  Company that (i) the Investor has full right, power, authority
                  and
                  capacity to enter into this Agreement and to consummate the transactions
                  contemplated hereby and has taken all necessary action to authorize
                  the
                  execution, delivery and performance of this Agreement, and (ii)
                  this
                  Agreement constitutes a valid and
                  binding

              

      

      
        
          
          

        

        
          -9-

          
            

          

        

        
          
          

        

      

      obligation
        of the Investor enforceable against the Investor in accordance with its terms,
        except as enforceability may be limited by applicable bankruptcy, insolvency,
        reorganization, moratorium or similar laws affecting creditors’ and contracting
        parties’ rights generally and except as enforceability may be subject to general
        principles of equity (regardless of whether such enforceability is considered
        in
        a proceeding in equity or at law).

      

      
        	5.4	
                The
                  Investor understands that nothing in the SEC Documents, this Agreement
                  or
                  any other materials presented to the Investor in connection with
                  the
                  purchase and sale of the Preferred Shares constitutes legal, tax
                  or
                  investment advice. The Investor has consulted such legal, tax and
                  investment advisors as it, in its sole discretion, has deemed necessary
                  or
                  appropriate in connection with its purchase of the Preferred
                  Shares.

              

      

      

      
        	6.	
                Survival
                  of Representations, Warranties and Agreements. Notwithstanding
                  any
                  investigation made by any party to this Agreement, all covenants,
                  agreements, representations and warranties made herein by the Company
                  and
                  the Investor shall survive the execution of this Agreement, the
                  delivery
                  to the Investor of the Preferred Shares being purchased and the
                  payment
                  therefor.

              

      

      

      
        	7.	
                Registration
                  of the Warrant Shares and the Conversion Shares; Compliance with
                  the
                  Securities Act.

              

      

      

      
        	7.1	
                Registration.
                  The Company shall use commercially reasonable efforts to file a
                  Registration Statement with the SEC registering the resale of the
                  maximum
                  number of shares of Common Stock to be issued upon conversion of
                  the
                  Preferred Stock and exercise of the Warrants within 90 days of
                  closing.
                  The Company shall use commercially reasonable efforts to have the
                  Registration Statement declared effective within 120 days after
                  the
                  initial filing with the SEC.  The terms of such registration rights
                  shall be set forth in a Registration Rights Agreement substantially
                  in the
                  form of Exhibit C attached herein (the “Registration Rights Agreement”).
                  In the event that the Company is unable to have the Registration
                  Statement
                  declared effective as set forth herein due to limitations imposed
                  by the
                  Securities and Exchange Commission on the registration of shares
                  for
                  resale on behalf of selling security holders, such inability shall
                  not be
                  considered a breach of the Company’s obligations under the
                  Agreements.

              

      

      

      
        	7.2	
                Rule
                  144. The Company covenants that it will file the reports required
                  to be
                  filed by it under the Securities Act and the Exchange Act and the
                  rules
                  and regulations adopted by the SEC thereunder (or, if the Company
                  is not
                  required to file such reports, it will, upon the request of the
                  Investor
                  holding Securities purchased hereunder made after the first anniversary
                  of
                  the Closing Date, make publicly available such information as necessary
                  to
                  permit sales of the Conversion Shares pursuant to Rule 144 under
                  the
                  Securities Act), and it will take such further action as the Investor
                  may
                  reasonably request, all to the extent required from time to time
                  to enable
                  the Investor to sell the Conversion Shares purchased hereunder
                  without
                  registration under the Securities Act within the limitation of
                  the
                  exemptions provided by (a) Rule 144 under the Securities Act, as
                  such rule
                  may be amended from time to time, or (b) any similar rule or regulation
                  hereafter adopted by the SEC.

              

      

      

      
        	8.	
                Covenants
                  (post Closing).

              

      

      

      
        	8.1	
                Short
                  Selling. For a period of three years from the date hereof, Investor
                  shall
                  not enter into or affect any “short sales” (as such term is defined in
                  Rule 3b-3 of the Securities Exchange Act of 1934) of the Company’s
                  securities or hedging transactions which establishes a net short
                  position.

              

      

      

      
        	9.	
                Notices.
                  All notices, requests, consents and other communications hereunder
                  shall
                  be in writing, shall be mailed (A) if within the United States
                  by
                  first-class registered mail, Express Mail or nationally recognized
                  overnight express courier, postage prepaid, or by facsimile, or
                  (B) if
                  delivered from outside the United States, by International Federal
                  Express
                  or facsimile, and shall be deemed given (i) if delivered by first-class
                  registered mail, three business days after so mailed, (ii) if delivered
                  by

              

      

      
        
          
          

        

        
          -10-

          
            

          

        

        
          
          

        

      

      Express
        Mail or a nationally recognized overnight carrier, one business day after
        so
        mailed, (iii) if delivered by International Federal Express, two business
        days
        after so mailed, (iv) if delivered by facsimile, upon electronic confirmation
        of
        receipt and shall be delivered as addressed as follows:

      

      

      
        	
              	(a)	
                if
                  to the Company, to:

              

      

      

      PLASTINUM
        POLYMER TECHNOLOGIES CORP. 

      245
        Park
        Avenue, 39th
        Floor

      New
        York,
        NY 10167

      USA

      Tel:
        + 1
        212 792 41 04

      Cell:
        +
        41 79 213 39 66

      Fax:
        + 41
        1 274 22 59

       

      with
        a
        copy to:

       

      Mr.
        Alan
        C. Ederer

      Westerman
        Ball Ederer Miller & Sharfstein LLP

      170
        Old
        Country Road, 4th floor

      Mineola,
        NY, 11501

      USA

      Tel:
        +1
        516.622.9200 ext 410

      Fax:
        + 1
        516 977 3056

       

      
        	
              	(b)	
                if
                  to the Investor, at its address on the signature page hereto, or
                  at such
                  other address or addresses as may have been furnished to the Company
                  in
                  writing

              

      

      

      
        	10.	
                Changes.
                  This Agreement may not be modified or amended except pursuant to
                  an
                  instrument in writing signed by the Company and the
                  Investor.

              

      

      

      
        	11.	
                Headings.
                  The headings of the various sections of this Agreement have been
                  inserted
                  for convenience of reference only and shall not be deemed to be
                  part of
                  this Agreement.

              

      

      

      
        	12.	
                Severability.
                  In case any provision contained in this Agreement should be invalid,
                  illegal or unenforceable in any respect, the validity, legality
                  and
                  enforceability of the remaining provisions contained herein shall
                  not in
                  any way be affected or impaired
                  thereby.

              

      

      

      
        	13.	
                Governing
                  Law. This Agreement shall be governed by, and construed in accordance
                  with, the internal laws of the State of New York, without giving
                  effect to
                  the principles of conflicts of law.

              

      

      

      
        	14.	
                Entire
                  Agreement. This Agreement constitutes the entire agreement between
                  the
                  parties hereto pertaining to the subject matter hereof, and any
                  and all
                  other written or oral agreements relating to such subject matter
                  are
                  expressly cancelled.

              

      

      

      
        	15.	
                Finders’
                  Fees. Neither the Company nor the Investor nor any affiliate thereof
                  has
                  incurred any obligation which will result in the obligation of
                  the other
                  party to pay any finder’s fee or commission in connection with this
                  transaction, except for fees payable by the Company to placement
                  agent in
                  connection with the sale of Preferred Shares
                  hereunder.

              

      

      
        
          
          

        

        
          -11-

          
            

          

        

        
          
          

        

      

      
        	16.	
                Counterparts.
                  This Agreement may be executed in two or more counterparts, each
                  of which
                  shall constitute an original, but all of which, when taken together,
                  shall
                  constitute but one instrument, and shall become effective when
                  one or more
                  counterparts have been signed by each party hereto and delivered
                  (including by facsimile) to the other
                  parties.

              

      

      

      
        	17.	
                Confidential
                  Information; 8-K Filing. Investor represents to the Company that,
                  at all
                  times during the Company’s offering of the Preferred Shares, Investor has
                  maintained in confidence all non-public information regarding the
                  Company
                  received by Investor from the Company or its agents, has not traded
                  in the
                  Company’s securities on the basis of any non-public information and
                  covenants that it will continue to maintain in confidence such
                  information
                  until such information becomes generally publicly available, other
                  than
                  through a violation of this provision by Investor or its agents.
                  Within
                  four (4) business days after the Closing Date, the Company shall
                  file a
                  Form 8-K concerning the Agreements and the transactions contemplated
                  thereby, which Form 8-K shall attach a Form of the Securities Purchase
                  Agreement and the Registration Rights Agreement as exhibits to
                  such Form
                  8-K (the “8-K Filing”). From and after the 8-K Filing, the Company hereby
                  acknowledges that no Investor shall be in possession of any material
                  nonpublic information received from the Company or any of its respective
                  officers, directors, employees or agents, that is not disclosed
                  in the 8-K
                  Filing.

              

      

      

      
        	18.	
                Successors
                  and Assigns. This Agreement shall inure to the benefit of and be
                  binding
                  upon the successors and permitted assigns of the Company and the
                  Investor,
                  including without limitation and without the need for an express
                  assignment, affiliates of the Investor. With respect to transfers
                  that are
                  not made pursuant to the Registration Rights Agreement, the rights
                  and
                  obligations of an Investor under this Agreement shall be automatically
                  assigned by the Investor to any transferee of all or any portion
                  of the
                  Investor’s Shares who is a
                  Permitted

              

      

      

      Transferee
        (as defined below); provided, however, that within two business days prior
        to
        the transfer, (i) the Company is provided notice of the transfer including
        the
        name and address of the transferee and the number of Shares transferred;
        and
        (ii) that such transferee agrees in writing to be bound by the terms of this
        Agreement. (For purposes of this Agreement, a “Permitted Transferee” shall mean
        any person who (a) is an “accredited investor,” as that term is defined in Rule
        501(a) of Regulation D under the Securities Act and (b) is a transferee of
        at
        least 25% of the Investor’s Shares received in a transaction permitted under the
        securities laws of the United States). Upon any transfer permitted by the
        second
        sentence of this Section 18, the Company shall be obligated to such transferee
        to perform all of its covenants under this Agreement as if such transferee
        were
        an Investor.

      

      
        	19.	
                Access
                  to Information. From and after the date hereof through the Closing,
                  on
                  reasonable notice to the Company, the Company shall permit access
                  to, and
                  shall make available to the Investors’ representatives and their counsel
                  for inspection, such information and documents as the Investors
                  reasonably
                  request, and shall make available at reasonable times and to a
                  reasonable
                  extent officers and employees of the Company (who are at the Vice
                  President level and above) to discuss the business and affairs
                  of the
                  Company.

              

      

      

      
        	20.	
                Further
                  Assurances. The Company shall provide such further documentation
                  and take
                  such further steps as may be reasonably requested by Investors
                  in
                  connection with the issuance and sale of the Preferred Shares and
                  the
                  Company’s obligations pursuant to the Transaction
                  Documents.

              

      

      

      

        
          
            
            

          

          
            -12-

            
              

            

          

          
            
            

          

        

      Schedule
        I

      

      

      

      

      Investors

      

      [Names]

      

      
        
          
          

        

        
          -13-

          
            

          

        

        
          
          

        

      

      Schedule
        4.5

      

      Capitalization
        as of September 30, 2007

      

      Shares
        of
        Common Stock outstanding: 96,409,836

      

      Shares
        of
        Preferred Stock outstanding: None.

      

      Warrants
        outstanding for the purchase of 22,678,034 shares of Common Stock.

      

      Debt
        convertible into 1,000,000 shares of Common Stock.

      

      Options
        outstanding for the purchase of 3,000,000 shares of Common Stock.

      

      

        
          
            
            

          

          
            -14-

            
              

            

          

          
            
            

          

        

      EXHIBIT
        A

      

      PLASTINUM
        POLYMER TECHNOLOGIES CORP. INVESTOR QUESTIONNAIRE

      (ALL
        INFORMATION WILL BE TREATED CONFIDENTIALLY)

      

      To: Plastinum
        Polymer Technologies Corp.

      

      This
        Investor Questionnaire (“Questionnaire”) must be completed by each potential
        investor in connection with the offer and sale of shares of the Company’s Series
        B-1 Convertible Preferred Stock (the “Preferred Shares”) and warrants to
        purchase shares of the Company’s Common Stock (collectively, the “Securities”).
        The Securities are being offered and sold by Plastinum Polymer Technologies
        Corp. (the “Company”) without registration under the Securities Act of 1933, as
        amended (the “Act”), and the securities laws of certain states, in reliance on
        the exemptions contained in Section 4(2) of the Act and on Regulation D
        promulgated thereunder and in reliance on similar exemptions under applicable
        state laws. The Company must determine that a potential investor meets certain
        suitability requirements before offering or selling the Securities to such
        investor. The purpose of this Questionnaire is to assure the Company that
        each
        investor will meet the applicable suitability requirements. The information
        supplied by the potential investor will be used in determining whether such
        investor meets such criteria, and reliance on the private offering exemption
        from registration is based in part on the information supplied in this
        Questionnaire.

       

      This
        Questionnaire does not constitute an offer to sell or a solicitation of an
        offer
        to buy any security. Except as expressly permitted herein, the potential
        investor’s answers are to be kept strictly confidential.

       

      However,
        by signing this Questionnaire the potential investor will be authorizing
        the
        Company to provide a completed copy of this Questionnaire to such parties
        as the
        Company deems appropriate in order to ensure that the offer and sale of the
        Securities will not result in a violation of the Act or the securities laws
        of
        any state, and that the potential investor otherwise satisfies the suitability
        standards applicable to purchasers of  the
        Securities. All potential investors must answer all applicable questions
        and
        complete, date and sign this Questionnaire. Please print or type the responses
        and attach additional sheets of paper if necessary to complete
        the answers to any item.

      

      A. BACKGROUND
        INFORMATION

      

      Name:
         ____________________________________________________________________________

      

      Business
        Address:
        ___________________________________________________________________

                                                                                                           
        (Number and Street)

      

      _________________________ 
        _________________________ _________________________

                                
        (City)                                                  
(State)                                             
(Zip
        Code)

      

      Telephone
        Number: _____________________________________  

      

      

      Residence
        Address:
        ___________________________________________________________________

      (Number
        and Street)

       

      

      _________________________ 
        _________________________ _________________________

                             
        (City)                                                       
(State)                                           
(Zip
        Code)

      

       

      Telephone
        Number: _____________________________________  

      
        
          
          

        

        
          -15-

          
            

          

        

        
          
          

        

      

      If
        an individual:

      

      Age: _____
          Citizenship:
        _______________ Where registered to vote: : _______________ 

      

      If
        a
        corporation, partnership, limited liability company, trust or other
        entity:

      

      Type
        of
        entity:____________________________________________________________

      

      State
        of
        formation: __________________
        Date of formation: __________________ 

      

      Social
        Security or Taxpayer Identification No. ____________________________________
        

      

      Send
        all
        correspondence to (check one): ___
        Residence Address ___
        Business Address 

      

      B. STATUS
        AS ACCREDITED INVESTOR

      

      The
        undersigned is an “accredited investor” as such term is defined in Regulation D
        under the Act, as at the time of the sale of the Preferred Shares the
        undersigned falls within one or more of the following categories (Please
        initial one or more, as applicable):1

      

      _____
        (1) a
        bank as
        defined in Section 3(a)(2) of the Act, or a savings and loan association
        or
        other institution as defined in Section 3(a)(5)(A) of the Act whether acting
        in
        its individual or fiduciary capacity; a broker or dealer registered pursuant
        to
        Section 15 of the Securities Exchange Act of 1934; an insurance company as
        defined in Section 2(13) of the Act; an investment company registered under
        the
        Investment Corporation Act of 1940 or a business development company as defined
        in Section 2(a)(48) of that Act; a Small Business Investment Corporation
        licensed by the U.S. Small Business Administration under Section 301(c) or
        (d)
        of the Small Business Investment Act of 1958; a plan established and maintained
        by a state, its political subdivisions, or any agency or instrumentality
        of a
        state or its political subdivisions for the benefit of its employees, if
        such
        plan has total assets in excess of $5,000,000; an employee benefit plan within
        the meaning of the Employee Retirement Income Security Act of 1974 if the
        investment decision is made by a plan fiduciary, as defined in Section 3(21)
        of
        such Act, which is either a bank, savings and loan association, insurance
        company, or registered investment adviser, or if the employee benefit plan
        has
        total assets in excess of $5,000,000 or, if a self-directed plan, with the
        investment decisions made solely by persons that are accredited
        investors;

      

      _____
        (2) a
        private
        business development company as defined in Section 202(a)(22) of the Investment
        Advisers Act of 1940;

      _____
        (3) an
        organization described in Section 501(c)(3) of the Internal Revenue Code
        of
        1986, as amended, corporation, Massachusetts or similar business trust, or
        partnership, not formed for the specific purpose of acquiring the Securities
        offered, with total assets in excess of $5,000,000;

      

      _____
        (4) a
        natural
        person whose individual net worth, or joint net worth with that person’s spouse,
        at the time of such person’s purchase of the Preferred Shares
        exceeds$1,000,000;

      

      
        
          

        

      

      1 As
        used in this Questionnaire, the tem “net worth” means the excess of total assets
        over total liabilities. In computing net worth for the purpose of subsection
        (4), the principal residence of the investor must be valued at cost, including
        cost of improvements, or at recently appraised value by an institutional
        lender
        making a secured loan, net of encumbrances. In determining income, the investor
        should add to the investor’s adjusted gross income any amounts attributable to
        tax exempt income received, losses claimed as a limited partner in any limited
        partnership, deductions claimed for depiction, contributions to an IRA or
        KEOGH
        retirement plan, alimony payments, and any amount by which income from long-term
        capital gains has been reduced in arriving at adjusted gross
        income.

      
        
          
          

        

        
          -16-

          
            

          

        

        
          
          

        

      

      _____
        (5) a
        natural
        person who had an individual income in excess of $200,000, or joint income
        with
        that person’s spouse in excess of $300,000, in 2005 and 2006 and has a
        reasonable expectation of reaching the same income level in 2007;

      

      _____
        (6) a
        trust,
        with total assets in excess of $5,000,000, not formed for the specific purpose
        of acquiring the Securities offered, whose purchase is directed by a
        sophisticated person as described in Rule 

      506(b)(2)(ii)
        of Regulation D; and

      

      _____
        (7) an
        entity
        in which all of the equity owners are accredited investors (as defined
        above).

      

      C. REPRESENTATIONS

      

      The
        undersigned hereby represents and warrants to the Company as
        follows:

      

      
        	1.	
                Any
                  purchase of the Securities would be solely for the account of the
                  undersigned and not for the account of any other person or with
                  a view to
                  any resale, fractionalization, division, or distribution
                  thereof.

              

      

      

      
        	2.	
                The
                  information contained herein is complete and accurate and may be
                  relied
                  upon by the Company, and the undersigned will notify the Company
                  immediately of any material change in any of such information occurring
                  prior to the closing, if any, with respect to the purchase of Preferred
                  Shares by the undersigned or any
                  co-purchaser.

              

      

      

      
        	3.	
                There
                  are no suits, pending litigation, or claims against the undersigned
                  that
                  could materially affect the net worth of the undersigned as reported
                  in
                  this Questionnaire.

              

      

      

      
        	4.	
                The
                  undersigned is aware that, the Preferred Shares, the Warrant Shares
                  and
                  the Conversion Shares will not be subject to ready liquidation.
                  The
                  overall commitment of the undersigned to investments which are
                  not readily
                  marketable is not excessive in view of the undersigned’s net worth and
                  financial circumstances, and any purchase of the Preferred Shares
                  will not
                  cause such commitment to become excessive. The undersigned is able
                  to bear
                  the economic risk of an investment in the
                  Securities.

              

      

      

      
        	5.	
                In
                  addition to reviewing the Company’s filings with the Securities and
                  Exchange Commission, the undersigned has carefully considered the
                  potential risks relating to the Corporation and a purchase of the
                  Preferred Shares, and fully understands that the Securities are
                  speculative investments which involve a high degree of risk of
                  loss of the
                  undersigned’s entire investment.

              

      

      

      

      

      

        
          
            
            

          

          
            -17-

            
              

            

          

          
            
            

          

        

      IN
        WITNESS WHEREOF, the undersigned has executed this Questionnaire as of this
        ________ day of __________, 2007, and declares under oath that it is truthful
        and correct.

      

       

      Print
        Name: _______________________________________________

      

      

       

      By:  _______________________________________________

      (Signature)

      

       

      Title:  _______________________________________________

      (required
        for any purchaser that is a corporation, partnership, trust or other
        entity)

       

      
        
           

        

        
          -18-REGISTRATION
      RIGHTS AGREEMENT

     

    This
      Registration Rights Agreement (this “Agreement”) is made and entered into as of
      November 6, 2007, by and among Plastinum Polymer Technologies Corp., a Delaware
      corporation (the “Company”), on the one hand, and the purchasers signatory
      hereto (each such purchaser, a “Purchaser” and collectively, the Purchasers”)
      and those shareholders of the Company listed on Exhibit A (the “Shareholders”),
      on the other hand.

    

    This
      Agreement is made pursuant to the Securities Purchase Agreement, dated as of
      the
      date hereof among the Company and the Purchasers (the “Purchase Agreement”)
      pursuant to which the Company is issuing to Purchasers shares of the Company’s
      Series B-1 Preferred Stock and other sub-series of the Company’s Series B
      Preferred Stock from time to time (collectively, the “Series B Preferred Stock”)
      which are convertible into shares of the Company’s Common Stock (the “Conversion
      Shares”) and warrants to purchase shares of the Company’s Common Stock (the
“Warrant Shares”).

    

    The
      Company, and the Purchasers hereby agree as follows:

    

    
      	1.	
              Definitions.
                Capitalized terms used and not otherwise defined herein that are
                defined
                in the Purchase Agreement shall have the meanings given such terms
                in the
                Purchase Agreement. As used in this Agreement, the following terms
                shall
                have the following meanings:

            

    

    

    Agreement

    

    “Closing”
      means the closing of the transactions contemplated by the Purchase

    

    “Dividend
      Shares” means shares of the Company’s Common Stock which may be issued by the
      Company as dividends in respect of the Series B Preferred Stock.

    

    “Effectiveness
      Date” means, with respect to the Registration Statement required to be filed
      hereunder, the earlier of (a) the 120th calendar day following the date of
      the
      filing the Registration Statement, and (b) the fifth Trading Day following
      the
      date on which the Company is notified by the Commission that the Registration
      Statement will not be reviewed or is no longer subject to further review and
      comments.

    

    “Effectiveness
      Period” shall have the meaning set forth in Section 2.

    

    “Filing
      Date” means, with respect to the Registration Statement required to be filed
      hereunder, the 90th calendar day following the date of the date of the
      Closing.

    

    “Holder”
      or “Holders” means the holder or holders, as the case may be, from time to time,
      of Registrable Securities.

    

    “Indemnified
      Party” shall have the meaning set forth in Section 5(c).

    

    “Indemnifying
      Party” shall have the meaning set forth in Section 5(c).

    

    “Losses”
      shall have the meaning set forth in Section 5(a).

    

    “Plan
      of
      Distribution” shall have the meaning set forth in Section 2.

    

    “Proceeding”
      means an action, claim, suit, investigation or proceeding (including, without
      limitation, an investigation or partial proceeding, such as a deposition),
      whether commenced or threatened.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    “Prospectus”
      means the prospectus included in the Registration Statement (including, without
      limitation, a prospectus that includes any information previously omitted from
      a
      prospectus filed as part of an effective registration
      statement in reliance upon Rule 430A promulgated under the Securities Act),
      as
      amended or supplemented by any prospectus supplement, with respect to the terms
      of the offering of any portion of the Registrable Securities covered by the
      Registration Statement, and all other amendments and supplements to the
      Prospectus, including post-effective amendments, and all material incorporated
      by reference or deemed to be incorporated by reference in such
      Prospectus.

    

    “Registrable
      Securities” means, as to this Agreement only, (a) all of the Conversion Shares,
      (b) all of the Warrant Shares, and (c) all of the Dividend Shares together,
      with
      any shares of Common Stock issued or issuable
      upon any stock split, dividend or other distribution, recapitalization or
      similar event with respect to the foregoing.

    

    “Registration
      Statement” means the registration statements required to be filed hereunder,
      including (in each case) the Prospectus, amendments and supplements to the
      registration statement or Prospectus, including pre- and post-effective
      amendments, all exhibits thereto, and all material incorporated by reference
      or
      deemed to be incorporated by reference in the registration
      statement.

    

    “Rule
      415” means Rule 415 promulgated by the Commission pursuant to the Securities
      Act, as such Rule may be amended from time to time, or any similar rule or
      regulation hereafter adopted by the Commission having substantially the same
      purpose and effect as such Rule.

    

    “Rule
      424” means Rule 424 promulgated by the Commission pursuant to the Securities
      Act, as such Rule may be amended from time to time, or any similar rule or
      regulation hereafter adopted by the Commission having substantially the same
      purpose and effect as such Rule.

    

    “Selling
      Shareholder Questionnaire” shall have the meaning set forth in
      Section

    

    2.    Registration

    

    On
      or
      prior to the Filing Date, the Company shall use commercially reasonable efforts
      to prepare and file with the Commission the Registration Statement covering
      the
      resale of all of the Registrable Securities for an offering to be made on a
      continuous basis pursuant to Rule 415. The Registration Statement required
      hereunder shall contain (except if otherwise directed by the Holders)
      substantially the “Plan of Distribution” attached hereto as Annex A. Subject to
      the terms of this Agreement, the Company shall use commercially reasonable
      efforts to cause the Registration Statement to be declared effective under
      the
      Securities Act as promptly as possible after the filing thereof, but in any
      event not later than the Effectiveness Date, and shall use its best efforts
      to
      keep the Registration Statement continuously effective under the Securities
      Act
      until the date when all Registrable Securities covered by the Registration
      Statement have been sold or may be sold without volume restrictions pursuant
      to
      Rule 144(k) as determined by the counsel to the Company pursuant to a written
      opinion letter to such effect, addressed and acceptable to the Company’s
      transfer agent and the affected Holders (the “Effectiveness Period”). In the
      event that the Company is unable to have the Registration Statement declared
      effective by the Effectiveness Date due to limitations imposed by the Securities
      and Exchange Commission on the registration of shares for resale on behalf
      of
      selling security holders, such inability shall not be considered a breach of
      the
      Company’s obligations under this Agreement.

    

    3.    Registration
      Procedures

    

    In
      connection with the Company’s registration obligations hereunder, the Company
      shall:

    

    
      	
            	(a)	
              Not
                less than five Trading Days prior to the filing of the Registration
                Statement or any related Prospectus or any amendment or supplement
                thereto, the Company shall, (i) furnish to the Holders copies of
                any
                disclosure relating to the Holders, including but not limited to
                the

            

    

    
      
         

      

      
        -2-

        
          

        

      

      
         

      

    

    entire
      Selling Stockholder and Plan of Distribution sections which sections shall
      be
      subject to the review of such Holders, and (ii) cause its officers and
      directors, counsel and independent certified public accountants to respond
      to
      such inquiries as shall be necessary, in the reasonable opinion of respective
      counsel to conduct a reasonable investigation within the meaning of the
      Securities Act. The Company shall not file the Registration Statement or any
      such prospectus or any amendments or supplements thereto to which the Holders
      of
      a majority of the Registrable Securities shall reasonably object in good faith,
      provided that the Company is notified of such objection in writing no later
      than
      two Trading Days after the Holders have been so furnished copies of such
      documents. Prior to any filing relating to the Registration Statement, each
      Holder agrees to furnish to the Company a completed Questionnaire in the form
      attached to this Agreement as Annex B (a “Selling Shareholder Questionnaire”)
      within five Trading Days of written request by the Company.

    

    
      	
            	(b)	
               

            

    

     

    
      	
            	(i)	
              Prepare
                and file with the Commission such amendments, including post-effective
                amendments, to the Registration Statement and the Prospectus used
                in
                connection therewith as may be necessary to keep the Registration
                Statement continuously effective as to the applicable Registrable
                Securities for the Effectiveness Period and prepare and file with
                the
                Commission such additional Registration Statements in order to register
                for resale under the Securities Act all of the Registrable Securities;
                

            

    

    
      	
            	(ii)	
              cause
                the related Prospectus to be amended or supplemented by any required
                Prospectus supplement, and as so supplemented or amended to be filed
                pursuant to Rule 424; 

            

    

    
      	
            	(iii)	
              respond
                as promptly as reasonably practicable to any comments received from
                the
                Commission with respect to the Registration Statement or any amendment
                thereto and, as promptly as reasonably practicable, upon request,
                provide
                the Holders upon request true and complete copies of all correspondence
                from and to the Commission relating to the Registration Statement;
                and
                

            

    

    
      	
            	(iv)	
              comply
                in all material respects with the provisions of the Securities Act
                and the
                Exchange Act with respect to the disposition of all Registrable Securities
                covered by the Registration Statement during the applicable period
                in
                accordance with the intended methods of disposition by the Holders
                thereof
                set forth in the Registration Statement as so amended or in such
                Prospectus as so supplemented.

            

    

    

    
      	
            	(c)	
              Notify
                the Holders of Registrable Securities to be sold as promptly as reasonably
                practicable and (if requested by any such Person) confirm such notice
                in
                writing promptly following the day 

            

    

     

    
      	
            	(i)	
               

            

    

    
      	
            	(A)	
              when
                a Prospectus or any Prospectus supplement or post- effective amendment
                to
                the Registration Statement is proposed to be filed;
                

            

    

    
      	
            	(B)	
              when
                the Commission notifies the Company whether there will be a “review” of
                the Registration Statement and whenever the Commission comments in
                writing
                on the Registration Statement (the Company shall upon request provide
                true
                and complete copies thereof and all written responses thereto to
                each of
                the Holders); and 

            

    

    
      	
            	(C)	
              with
                respect to the Registration Statement or any post-effective amendment,
                when the same has become effective;

            

    

    
      	
            	(ii)	
              of
                any request by the Commission or any other Federal or state governmental
                authority during the period of effectiveness of
                the

            

    

    
      
         

      

      
        -3-

        
          

        

      

      
         

      

    

    Registration
      Statement for amendments or supplements to the Registration Statement or
      Prospectus or for additional information; 

    
      	
            	(iii)	
              of
                the issuance by the Commission or any other federal or state governmental
                authority of any stop order suspending the effectiveness of the
                Registration Statement covering any or all of the Registrable Securities
                or the initiation of any Proceedings for that purpose;
                

            

    

    
      	
            	(iv)	
              of
                the receipt by the Company of any notification with respect to the
                suspension of the qualification or exemption from qualification of
                any of
                the Registrable Securities for sale in any jurisdiction, or the initiation
                or threatening of any Proceeding for such purpose; and
                

            

    

    
      	
            	(v)	
              of
                the occurrence of any event or passage of time that makes the financial
                statements included in the Registration Statement ineligible for
                inclusion
                therein or any statement made in the Registration Statement or Prospectus
                or any document incorporated or deemed to be incorporated therein
                by
                reference untrue in any material respect or that requires any revisions
                to
                the Registration Statement, Prospectus or other documents so that,
                in the
                case of the Registration Statement or the Prospectus, as the case
                may be,
                it will not contain any untrue statement of a material fact or omit
                to
                state any material fact required to be stated therein or necessary
                to make
                the statements therein, in light of the circumstances under which
                they
                were made, not misleading.

            

    

    

    
      	
            	(d)	
              Use
                commercially reasonable efforts to avoid the issuance of, or, if
                issued,
                obtain the withdrawal of 

            

    

    
      	
            	(i)	
              any
                order suspending the effectiveness of the Registration Statement,
                or
                

            

    

    
      	
            	(ii)	
              any
                suspension of the qualification (or exemption from qualification)
                of any
                of the Registrable Securities for sale in any jurisdiction, at the
                earliest practicable moment.

            

    

    

    
      	 	
              (e)

            	
              Furnish
                to each Holder, without charge and upon request, at least one conformed
                copy of the Registration Statement and each amendment thereto, including
                financial statements and schedules, all documents incorporated or
                deemed
                to be incorporated therein by reference to the extent requested by
                such
                Person, and all exhibits to the extent requested by such Person (including
                those previously furnished or incorporated by reference) promptly
                after
                the filing of such documents with the
                Commission.

            

    

    

    
      	 	
              (f)

            	
              Promptly
                deliver to each Holder, without charge and upon request, as many
                copies of
                the Prospectus or Prospectuses (including each form of prospectus)
                and
                each amendment or supplement thereto as such Persons may reasonably
                request in connection with resales by the Holder of Registrable
                Securities. Subject to the terms of this Agreement, the Company hereby
                consents to the use of such Prospectus and each amendment or supplement
                thereto by each of the selling Holders in connection with the offering
                and
                sale of the Registrable Securities covered by such Prospectus and
                any
                amendment or supplement thereto, except after the giving on any notice
                pursuant to Section 3(c).

            

    

    

    
      	 	
              (g)

            	
              Prior
                to any resale of Registrable Securities by a Holder, use its commercially
                reasonable efforts to register or qualify or cooperate with the selling
                Holders in connection with the registration or qualification (or
                exemption
                from the Registration or qualification) of such Registrable Securities
                for
                the resale by the Holder under the securities or Blue Sky laws of
                such
                jurisdictions within the United States as any Holder reasonably requests
                in writing, to keep the Registration or qualification (or exemption
                therefrom) effective during the Effectiveness Period and to do any
                and all
                other acts or things reasonably necessary to enable the disposition
                in
                such jurisdictions of the Registrable Securities covered by
                the

            

    

    
      
         

      

      
        -4-

        
          

        

      

      
         

      

    

    Registration
      Statement; provided, that the Company shall not be required to qualify generally
      to do business in any jurisdiction where it is not then so qualified, subject
      the Company to any tax in any such jurisdiction where it is not then so subject
      or file a general consent to service of process in any such
      jurisdiction.

    

    
      	 	
              (h)

            	
              If
                requested by the Holders, cooperate with the Holders to facilitate
                the
                timely preparation and delivery of certificates representing Registrable
                Securities to be delivered to a transferee pursuant to the Registration
                Statement, which certificates shall be free, to the extent permitted
                by
                the Purchase Agreement, of all restrictive legends, and to enable
                such
                Registrable Securities to be in such denominations and registered
                in such
                names as any such Holders may
                request.

            

    

    

    
      	 	
              (i)

            	
              Upon
                the occurrence of any event contemplated by Section 3(c)(v), as promptly
                as reasonably possible, prepare a supplement or amendment, including
                a
                post-effective amendment, to the Registration Statement or a supplement
                to
                the related Prospectus or any document incorporated or deemed to
                be
                incorporated therein by reference, and file any other required document
                so
                that, as thereafter delivered, neither the Registration Statement
                nor such
                Prospectus will contain an untrue statement of a material fact or
                omit to
                state a material fact required to be stated therein or necessary
                to make
                the statements therein, in light of the circumstances under which
                they
                were made, not misleading. If the Company notifies the Holders in
                accordance with clauses (ii) through (v) of Section 3(c) above to
                suspend
                the use of any Prospectus until the requisite changes to such Prospectus
                have been made, then the Holders shall suspend use of such Prospectus.
                The
                Company will use its best efforts to ensure that the use of the Prospectus
                may be resumed as promptly as is practicable. The Company shall be
                entitled to exercise its right under this Section 3(i) to suspend
                the
                availability of a Registration Statement and Prospectus, subject
                to the
                payment of partial liquidated damages pursuant to Section 2(b), for
                a
                period not to exceed 60 days (which need not be consecutive days)
                in any
                12 month period.

            

    

    

    
      	
            	(j)	
              Comply
                with all applicable rules and regulations of the
                Commission.

            

    

    

    
      	 	
              (k)

            	
              The
                Company may require each selling Holder to furnish to the Company
                a
                certified statement as to the number of shares of Common Stock
                beneficially owned by such Holder and, if required by the Commission,
                the
                person thereof that has voting and dispositive control over the Shares.
                During any periods that the Company is unable to meet its obligations
                hereunder with respect to the registration of the Registrable Securities
                solely because any Holder fails to furnish such information within
                three
                Trading Days of the Company’s request, any liquidated damages that are
                accruing at such time as to such Holder only shall be tolled and
                any Event
                that may otherwise occur solely because of such delay shall be suspended
                as to such Holder only, until such information is delivered to the
                Company.

            

    

    

    4.    Registration
      Expenses 

    

    All
      fees
      and expenses incident to the performance of or compliance with this Agreement
      by
      the Company shall be borne by the Company whether or not any Registrable
      Securities are sold pursuant to the Registration Statement. The fees and
      expenses referred to in the foregoing sentence shall include, without
      limitation, (i) all registration and filing fees (including, without limitation,
      fees and expenses with respect to filings required to be made with the Trading
      Market on which the Common Stock is then listed for trading, (ii) printing
      expenses (including, without limitation, expenses of printing certificates
      for
      Registrable Securities and of printing prospectuses if the printing of
      prospectuses is reasonably requested by the holders of a majority of the
      Registrable Securities included in the Registration Statement), (iii) messenger,
      telephone and delivery expenses, (iv) fees and disbursements of counsel for
      the
      Company, (v) Securities Act liability

    
      
         

      

      
        -5-

        
          

        

      

      
         

      

    

    insurance,
      if the Company so desires such insurance, and (vi) fees and expenses of all
      other Persons retained by the Company in connection with the consummation of
      the
      transactions contemplated by this Agreement. In addition, the Company shall
      be
      responsible for all of its internal expenses incurred in connection with the
      consummation of the transactions contemplated by this Agreement (including,
      without limitation, all salaries and expenses of its officers and employees
      performing legal or accounting duties), the expense of any annual audit and
      the
      fees and expenses incurred in connection with the listing of the Registrable
      Securities on any securities exchange as required hereunder. In no event shall
      the Company be responsible for any broker or similar commissions or, except
      to
      the extent provided for in the Transaction Documents, any legal fees or other
      costs of the Holders.

    

    5.    Indemnification

    

    
      	 	
              (a)

            	
              Indemnification
                by the Company. The Company shall, notwithstanding any termination
                of this
                Agreement, indemnify and hold harmless each Holder, the officers,
                directors, agents and employees of each of them, each Person who
                controls
                any such Holder (within the meaning of Section 15 of the Securities
                Act or
                Section 20 of the Exchange Act) and the officers, directors, agents
                and
                employees of each such controlling Person, to the fullest extent
                permitted
                by applicable law, from and against any and all losses, claims, damages,
                liabilities, costs (including, without limitation, reasonable attorneys’
                fees) and expenses (collectively, “Losses”), as incurred, arising out of
                or relating to any untrue or alleged untrue statement of a material
                fact
                contained in the Registration Statement, any Prospectus or any form
                of
                prospectus or in any amendment or supplement thereto or in any preliminary
                prospectus, or arising out of or relating to any omission or alleged
                omission of a material fact required to be stated therein or necessary
                to
                make the statements therein (in the case of any Prospectus or form
                of
                prospectus or supplement thereto, in light of the circumstances under
                which they were made) not misleading, except to the extent, but only
                to
                the extent, that 

            

    

    
      	
            	(i)	
              such
                untrue statements or omissions are based solely upon information
                regarding
                such Holder furnished in writing to the Company by such Holder expressly
                for use therein, or to the extent that such information relates to
                such
                Holder or such Holder’s proposed method of distribution of Registrable
                Securities and was reviewed and expressly approved in writing by
                such
                Holder expressly for use in the Registration Statement, such Prospectus
                or
                such form of Prospectus or in any amendment or supplement thereto
                (it
                being understood that the Holder has approved Annex A hereto for
                this
                purpose) or 

            

    

    
      	
            	(ii)	
              in
                the case of an occurrence of an event of the type specified in Section
                3(c)(ii)-(v), the use by such Holder of an outdated or defective
                Prospectus after the Company has notified such Holder in writing
                that the
                Prospectus is outdated or defective. The Company shall notify the
                Holders
                promptly of the institution, threat or assertion of any Proceeding
                of
                which the Company is aware in connection with the transactions
                contemplated by this Agreement.

            

    

    

    
      	 	
              (b)

            	
              Indemnification
                by Holders. Each Holder shall, severally and not jointly, indemnify
                and
                hold harmless the Company, its directors, officers, agents and employees,
                each Person who controls the Company (within the meaning of Section
                15 of
                the Securities Act and Section 20 of the Exchange Act), and the directors,
                officers, agents or employees of such controlling Persons, to the
                fullest
                extent permitted by applicable law, from and against all Losses,
                as
                incurred, to the extent arising out of or based solely upon: (x)
                such
                Holder’s failure to comply with the prospectus delivery requirements of
                the Securities Act or (y) any untrue or alleged untrue statement
                of a
                material fact contained in any Registration Statement, any Prospectus,
                or
                any form of prospectus, or in any amendment or supplement thereto
                or in
                any preliminary prospectus, or arising out of or relating to any
                omission
                or alleged omission

            

    

    
      
         

      

      
        -6-

        
          

        

      

      
         

      

    

    of
      a
      material fact required to be stated therein or necessary to make the statements
      therein not misleading (i) to the extent, but only to the extent, that such
      untrue statement or omission is contained in any information so furnished in
      writing by such Holder to the Company specifically for inclusion in the
      Registration Statement or such Prospectus or (ii) to the extent that

    
      	
            	(1)	
              such
                untrue statements or omissions are based solely upon information
                regarding
                such Holder furnished in writing to the Company by such Holder expressly
                for use therein, or to the extent that such information relates to
                such
                Holder or such Holder’s proposed method of distribution of Registrable
                Securities and was reviewed and expressly approved in writing by
                such
                Holder expressly for use in the Registration Statement (it being
                understood that the Holder has approved Annex A hereto for this purpose),
                such Prospectus or such form of Prospectus or in any amendment or
                supplement thereto or

            

    

    
      	
            	(2)	
              in
                the case of an occurrence of an event of the type specified in Section
                3(c)(ii)-(v), the use by such Holder of an outdated or defective
                Prospectus after the Company has notified such Holder in writing
                that the
                Prospectus is outdated or defective. In no event shall the liability
                of
                any selling Holder hereunder be greater in amount than the dollar
                amount
                of the net proceeds received by such Holder upon the sale of the
                Registrable Securities giving rise to such indemnification
                obligation.

            

    

    

    
      	 	
              (c)

            	
              Conduct
                of Indemnification Proceedings. If any Proceeding shall be brought
                or
                asserted against any Person entitled to indemnity hereunder (an
                “Indemnified Party”), such Indemnified Party shall promptly notify the
                Person from whom indemnity is sought (the “Indemnifying Party”) in
                writing, and the Indemnifying Party shall have the right to assume
                the
                defense thereof, including the employment of counsel reasonably
                satisfactory to the Indemnified Party and the payment of all fees
                and
                expenses incurred in connection with defense thereof; provided, that
                the
                failure of any Indemnified Party to give such notice shall not relieve
                the
                Indemnifying Party of its obligations or liabilities pursuant to
                this
                Agreement, except (and only) to the extent that it shall be finally
                determined by a court of competent jurisdiction (which determination
                is
                not subject to appeal or further review) that such failure shall
                have
                prejudiced the Indemnifying Party.

            

    

    

    An
      Indemnified Party shall have the right to employ separate counsel in any such
      Proceeding and to participate in the defense thereof, but the fees and expenses
      of such counsel shall be at the expense of such Indemnified Party or Parties
      unless: 

    
      	
            	(1)	
              The
                Indemnifying Party has agreed in writing to pay such fees and expenses;
                

            

    

    
      	
            	(2)	
              The
                Indemnifying Party shall have failed promptly to assume the defense
                of
                such Proceeding and to employ counsel reasonably satisfactory to
                such
                Indemnified Party in any such Proceeding; or

            

    

    
      	
            	(3)	
              The
                named parties to any such Proceeding (including any impleaded parties)
                include both such Indemnified Party and the Indemnifying Party, and
                such
                Indemnified Party shall reasonably believe that a material conflict
                of
                interest is likely to exist if the same counsel were to represent
                such
                Indemnified Party and the Indemnifying Party (in which case, if such
                Indemnified Party notifies the Indemnifying Party in writing that
                it
                elects to employ separate counsel at the expense of the Indemnifying
                Party, the Indemnifying Party shall not have the right to assume
                the
                defense thereof and the reasonable fees and expenses of one separate
                counsel shall be at the expense of the Indemnifying Party). The
                Indemnifying Party shall not be liable for any settlement of any
                such
                Proceeding effected without its written consent, which consent shall
                not
                be unreasonably withheld. No Indemnifying Party
                shall,

            

    

    
      
         

      

      
        -7-

        
          

        

      

      
         

      

    

    without
      the prior written consent of the Indemnified Party, effect any settlement of
      any
      pending Proceeding in respect of which any Indemnified Party is a party, unless
      such settlement includes an unconditional release of such Indemnified Party
      from
      all liability on claims that are the subject matter of such
      Proceeding.

    

    Subject
      to the terms of this Agreement, all reasonable fees and expenses of the
      Indemnified Party (including reasonable fees and expenses to the extent incurred
      in connection with investigating or preparing to defend such Proceeding in
      a
      manner not inconsistent with this Section) shall be paid to the Indemnified
      Party, as incurred, within ten Trading Days of written notice thereof to the
      Indemnifying Party; provided, that the Indemnified Party shall promptly
      reimburse the Indemnifying Party for that portion of such fees and expenses
      applicable to such actions for which such Indemnified Party is not entitled
      to
      indemnification hereunder, determined based upon the relative faults of the
      parties.

    

    
      	
            	(d)	
              Contribution.
                If a claim for indemnification under Section 5(a) or 5(b) is unavailable
                to an Indemnified Party (by reason of public policy or otherwise),
                then
                each Indemnifying Party, in lieu of indemnifying such Indemnified
                Party,
                shall contribute to the amount paid or payable by such Indemnified
                Party
                as a result of such Losses, in such proportion as is appropriate
                to
                reflect the relative fault of the Indemnifying Party and Indemnified
                Party
                in connection with the actions, statements or omissions that resulted
                in
                such Losses as well as any other relevant equitable considerations.
                The
                relative fault of such Indemnifying Party and Indemnified Party shall
                be
                determined by reference to, among other things, whether any action
                in
                question, including any untrue or alleged untrue statement of a material
                fact or omission or alleged omission of a material fact, has been
                taken or
                made by, or relates to information supplied by, such Indemnifying
                Party or
                Indemnified Party, and the parties’ relative intent, knowledge, access to
                information and opportunity to correct or prevent such action, statement
                or omission. The amount paid or payable by a party as a result of
                any
                Losses shall be deemed to include, subject to the limitations set
                forth in
                this Agreement, any reasonable attorneys’ or other reasonable fees or
                expenses incurred by such party in connection with any Proceeding
                to the
                extent such party would have been indemnified for such fees or expenses
                if
                the indemnification provided for in this Section was available to
                such
                party in accordance with its terms.

            

    

    

    The
      parties hereto agree that it would not be just and equitable if contribution
      pursuant to this Section 5(d) were determined by pro rata allocation or by
      any
      other method of allocation that does not take into account the equitable
      considerations referred to in the immediately preceding paragraph.
      Notwithstanding the provisions of this Section 5(d), no Holder shall be required
      to contribute, in the aggregate, any amount in excess of the amount by which
      the
      proceeds actually received by such Holder from the sale of the Registrable
      Securities subject to the Proceeding exceeds the amount of any damages that
      such
      Holder has otherwise been required to pay by reason of such untrue or alleged
      untrue statement or omission or alleged omission, except in the case of fraud
      by
      such Holder.

    

    The
      indemnity and contribution agreements contained in this Section are in addition
      to any liability that the Indemnifying Parties may have to the Indemnified
      Parties.

     

    6.    Miscellaneous

    

    
      	
            	(a)	
              Remedies.
                In the event of a breach by the Company or by a Holder, of any of
                their
                obligations under this Agreement, each Holder or the Company, as
                the case
                may be, in addition to being entitled to exercise all rights granted
                by
                law and under this Agreement, including recovery of damages, will
                be
                entitled to specific performance of its rights under this Agreement.
                The
                Company and each Holder agree that monetary damages would not provide
                adequate compensation for any losses incurred by reason of a breach
                by it
                of any of

            

    

    
      
         

      

      
        -8-

        
          

        

      

      
         

      

    

    the
      provisions of this Agreement and hereby further agrees that, in the event of
      any
      action for specific performance in respect of such breach, it shall waive the
      defense that a remedy at law would be adequate.

    

    
      	
            	(b)	
              Compliance.
                Each Holder covenants and agrees that it will comply with the prospectus
                delivery requirements of the Securities Act as applicable to it in
                connection with sales of Registrable Securities pursuant to the
                Registration Statement.

            

    

    

    
      	
            	(c)	
              Discontinued
                Disposition. Each Holder agrees by its acquisition of such Registrable
                Securities that, upon receipt of a notice from the Company of the
                occurrence of any event of the kind described in Section 3(c), such
                Holder
                will forthwith discontinue disposition of such Registrable Securities
                under the Registration Statement until such Holder’s receipt of the copies
                of the supplemented Prospectus and/or amended Registration Statement
                or
                until it is advised in writing (the “Advice”) by the Company that the use
                of the applicable Prospectus may be resumed, and, in either case,
                has
                received copies of any additional or supplemental filings that are
                incorporated or deemed to be incorporated by reference in such Prospectus
                or Registration Statement. The Company will use its best efforts
                to ensure
                that the use of the Prospectus may be resumed as promptly as it
                practicable. The Company agrees and acknowledges that any periods
                during
                which the Holder is required to discontinue the disposition of the
                Registrable Securities hereunder shall be subject to the provisions
                of
                Section 2(b).

            

    

    

    
      	
            	(d)	
              Piggy-Back
                Registrations. If at any time during the Effectiveness Period there
                is not
                an effective Registration Statement covering all of the Registrable
                Securities and the Company shall determine to prepare and file with
                the
                Commission a registration statement relating to an offering for its
                own
                account under the Securities Act of any of its equity securities,
                other
                than on Form S-4 or Form S-8 (each as promulgated under the Securities
                Act) or their then equivalents relating to equity securities to be
                issued
                solely in connection with any acquisition of any entity or business
                or
                equity securities issuable in connection with the stock option or
                other
                employee benefit plans, then the Company shall send to each Holder
                a
                written notice of such determination and, if within fifteen days
                after the
                date of such notice, any such Holder shall so request in writing,
                the
                Company shall include in such registration statement all or any part
                of
                such Registrable Securities such Holder requests to be registered,
                subject
                to customary underwriter cutbacks applicable to all holders of
                registration rights.

            

    

    

    
      	
            	(e)	
              Amendments
                and Waivers. The provisions of this Agreement, including the provisions
                of
                this sentence, may not be amended, modified or supplemented, and
                waivers
                or consents to departures from the provisions hereof may not be given,
                unless the same shall be in writing and signed by the Company and
                Holders
                of at least 66% of the then outstanding Registrable
                Securities.

            

    

    

    
      	
            	(f)	
              Notices.
                Any and all notices or other communications or deliveries required
                or
                permitted to be provided hereunder shall be made in accordance with
                the
                provisions of the Purchase
                Agreement.

            

    

    

    
      	
            	(g)	
              Successors
                and Assigns. This Agreement shall inure to the benefit of and be
                binding
                upon the successors and permitted assigns of each of the parties
                and shall
                inure to the benefit of each Holder. Each Holder may assign their
                respective rights hereunder in the manner and to the Persons as permitted
                under the Purchase Agreement.

            

    

    

    
      	
            	(h)	
              Execution
                and Counterparts. This Agreement may be executed in any number of
                counterparts, each of which when so executed shall be deemed to be
                an
                original and, all of which taken together shall constitute one and
                the
                same Agreement. In the event that
                any

            

    

    
      
         

      

      
        -9-

        
          

        

      

      
         

      

    

    signature
      is delivered by facsimile transmission, such signature shall create a valid
      binding obligation of the party executing (or on whose behalf such signature
      is
      executed) the same with the same force and effect as if such facsimile signature
      were the original thereof.

    

    
      	
            	(i)	
              Governing
                Law. All questions concerning the construction, validity, enforcement
                and
                interpretation
                of this Agreement shall be determined with the provisions of the
                Purchase
                Agreement.

            

    

    

    
      	
            	(j)	
              Cumulative
                Remedies. The remedies provided herein are cumulative and not exclusive
                of
                any remedies provided by law.

            

    

    

    
      	
            	(k)	
              Severability.
                If any term, provision, covenant or restriction of this Agreement
                is held
                by a court of competent jurisdiction to be invalid, illegal, void
                or
                unenforceable, the remainder of the terms, provisions, covenants
                and
                restrictions set forth herein shall remain in full force and effect
                and
                shall in no way be affected, impaired or invalidated, and the parties
                hereto shall use their commercially reasonable efforts to find and
                employ
                an alternative means to achieve the same or substantially the same
                result
                as that contemplated by such term, provision, covenant or restriction.
                It
                is hereby stipulated and declared to be the intention of the parties
                that
                they would have executed the remaining terms, provisions, covenants
                and
                restrictions without including any of such that may be hereafter
                declared
                invalid, illegal, void or
                unenforceable.

            

    

    

    
      	
            	(l)	
              Headings.
                The headings in this Agreement are for convenience of reference only
                and
                shall not limit or otherwise affect the meaning
                hereof.

            

    

    

    
      	 	
              (m)

            	
              Independent
                Nature of Holders’ Obligations and Rights. The obligations of each Holder
                hereunder are several and not joint with the obligations of any other
                Holder hereunder, and no Holder shall be responsible in any way for
                the
                performance of the obligations of any other Holder hereunder. Nothing
                contained herein or in any other agreement or document delivered
                at any
                closing, and no action taken by any Holder pursuant hereto or thereto,
                shall be deemed to constitute the Holders as a partnership, an
                association, a joint venture or any other kind of entity, or create
                a
                presumption that the Holders are in any way acting in concert with
                respect
                to such obligations or the transactions contemplated by this Agreement.
                Each Holder shall be entitled to protect and enforce its rights,
                including
                without limitation the rights arising out of this Agreement, and
                it shall
                not be necessary for any other Holder to be joined as an additional
                party
                in any proceeding for such purpose.

            

    

    

    

    [SIGNATURE
      PAGES FOLLOW]

    

    

    
      
         

      

      
        -10-

        
          

        

      

      
         

      

    

    IN
      WITNESS WHEREOF, the parties have executed this Registration Rights Agreement
      as
      of the date first written above.

    

    PLASTINUM
      POLYMER TECHNOLOGIES CORP. 

    

    

    

    By:

      
        

      

    

    Name:

    Title:

    

    

    

    

    

    

    [SIGNATURE
      PAGES OF PURCHASERS FOLLOW]

    

    

    

      
        
           

        

        
          -11-

          
            

          

        

        
           

        

      

    PURCHASER’S
      SIGNATURE PAGE TO PLASTINUM POLYMER TECHNOLOGIES CORP. REGISTRATION RIGHTS
      AGREEMENT

    

    
 

    (Name
      of
      Entity)

    

    

    

    By:

      
        

      

    

    Name:

    Title:

    

    

    

    
 

    [SIGNATURE
      PAGES CONTINUE]

    

    

    

      
        
           

        

        
          -12-

          
            

          

        

        
           

        

      

    

    ANNEX
      A

    

    PLAN
      OF DISTRIBUTION

    

    The
      Selling Stockholders (the “Selling Stockholders”) of the common stock (“Common
      Stock”) of Plastinum Polymer Technologies Corp., a Delaware corporation(the
“Company”) and any of their pledgees, assignees and successors-in-interest may,
      from time to time, sell any or all of their shares of Common Stock on any stock
      exchange, market or trading facility on which the shares are traded or in
      private transactions. These sales may be at fixed or negotiated prices. The
      Selling Stockholders may use any one or more of the following methods when
      selling shares:

    

    
      	•	
              Ordinary
                brokerage transactions and transactions in which the broker-dealer
                solicits purchasers;

            

    

    

    
      	•	
              Block
                trades in which the broker-dealer will attempt to sell the shares
                as agent
                but may position and resell a portion of the block as principal to
                facilitate the transaction;

            

    

    

    
      	•	
              Purchases
                by a broker-dealer as principal and resale by the broker-dealer for
                its
                account;

            

    

    

    
      	•	
              An
                exchange distribution in accordance with the rules of the applicable
                exchange;

            

    

    

    
      	•	
              Privately
                negotiated transactions;

            

    

    

    
      	•	
              Broker-dealers
                may agree with the Selling Stockholders to sell a specified number
                of such
                shares at a stipulated price per
                share;

            

    

    

    
      	•	
              A
                combination of any such methods of
                sale;

            

    

    

    
      	•	
              Through
                the writing or settlement of options or other hedging transactions,
                whether through an options exchange or otherwise;
                or

            

    

    

    
      	•	
              Any
                other method permitted pursuant to applicable
                law.

            

    

    

    The
      Selling Stockholders may also sell shares under Rule 144 under the Securities
      Act of 1933, as amended (the “Securities Act”), if available, rather than under
      this prospectus.

    

    Broker-dealers
      engaged by the Selling Stockholders may arrange for other brokers- dealers
      to
      participate in sales. Broker-dealers may receive commissions or discounts from
      the Selling Stockholders (or, if any broker-dealer acts as agent for the
      purchaser of shares, from the purchaser) in amounts to be negotiated. Each
      Selling Stockholder does not expect these commissions and discounts relating
      to
      its sales of shares to 

    exceed
      what is customary in the types of transactions involved. 

    

    The
      Selling Stockholders may loan or pledge the common stock to broker-dealers
      that
      in turn may sell these securities. The Selling Stockholders may also enter
      into
      option or other transactions with broker-dealers or other financial institutions
      or the creation of one or more derivative securities which require the delivery
      to such broker- dealer or other financial institution of shares offered by
      this
      prospectus, which shares such broker-dealer or other financial institution
      may
      resell pursuant to this prospectus (as supplemented or amended to reflect such
      transaction).

    

    The
      Selling Stockholders and any broker-dealers or agents that are involved in
      selling the shares may be deemed to be “underwriters” within the meaning of the
      Securities Act in connection with such sales. In such event, any commissions
      received by such broker-dealers or agents and any profit on the resale of
      the

    
      
         

      

      
        -13-

        
          

        

      

      
         

      

    

    shares
      purchased by them may be deemed to be underwriting commissions or discounts
      under the Securities Act. Each Selling Stockholder has informed the Company
      that
      it does not have any agreement or understanding,
      directly or indirectly, with any person to distribute the Common
      Stock.

    

    The
      Company is required to pay certain fees and expenses incurred by the Company
      incident to the registration of the shares. The Company has agreed to indemnify
      the Selling Stockholders against certain losses, claims, damages and
      liabilities, including liabilities under the Securities Act.

    

    Because
      Selling Stockholders may be deemed to be “underwriters” within the meaning of
      the Securities Act, they will be subject to the prospectus delivery requirements
      of the Securities Act. In addition, any securities covered by this prospectus
      which qualify for sale pursuant to Rule 144 under the Securities Act may be
      sold
      under Rule 144 rather than under this prospectus. Each Selling Stockholder
      has
      advised us that they have not entered into any agreements, understandings or
      arrangements with any underwriter or broker-dealer regarding the sale of the
      resale shares. There is no underwriter or coordinating broker acting in
      connection with the proposed sale of the resale shares by the Selling
      Stockholders.

    

    We
      agreed
      to keep this prospectus effective until the earlier of 

    
      	
            	(i)	
              the
                date on which the shares may be resold by the Selling Stockholders
                without
                registration and without regard to any volume limitations by reason
                of
                Rule 144(k) under the Securities Act or any other rule of similar
                effect
                or 

            

    

    
      	
            	(ii)	
              all
                of the shares have been sold pursuant to the prospectus or Rule 144
                under
                the Securities Act or any other rule of similar effect. The resale
                shares
                will be sold only through registered or licensed brokers or dealers
                if
                required under applicable state securities laws. In addition, in
                certain
                states, the resale shares may not be sold unless they have been registered
                or qualified for sale in the applicable state or an exemption from
                the
                registration or qualification requirement is available and is complied
                with.

            

    

    

    Under
      applicable rules and regulations under the Exchange Act, any person engaged
      in
      the distribution of the resale shares may not simultaneously engage in market
      making activities with respect to our common stock for a period of two business
      days prior to the commencement of the distribution. In addition, the Selling
      Stockholders will be subject to applicable provisions of the Exchange Act and
      the rules and regulations thereunder, including Regulation M, which may limit
      the timing of purchases and sales of shares of our common stock by the Selling
      Stockholders or any other person. We will make copies of this prospectus
      available to the Selling Stockholders and have informed them of the need to
      deliver a copy of this prospectus to each purchaser at or prior to the time
      of
      the sale.

    

    

    
      
        
           

        

        
          -14-

          
            

          

        

        
           

        

      

    

     

    ANNEX
      B

    

    PLASTINUM
      POLYMER TECHNOLOGIES CORP. 

    

    SELLING
      SECURITYHOLDER NOTICE AND QUESTIONNAIRE

    

    The
      undersigned beneficial owner of common stock, (the “Common Stock”), of Plastinum
      Polymer Technologies Corp., a Delaware corporation(the “Company”), (the
“Registrable Securities”) understands that the Company has filed or intends to
      file with the Securities and Exchange Commission (the “Commission”) a
      registration statement (the “Registration Statement”) for the registration and
      resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities
      Act”), of the Registrable Securities, in accordance with the terms of the
      Registration Rights Agreement, dated as of November 6, 2007 (the “Registration
      Rights Agreement”), among the Company and the Purchasers named therein. A copy
      of the Registration Rights Agreement is available from the Company upon request
      at the address set forth below. All capitalized terms not otherwise defined
      herein shall have the meanings ascribed thereto in the Registration Rights
      Agreement.

    

    Certain
      legal consequences arise from being named as a selling securityholder in the
      Registration Statement and the related prospectus. Accordingly, holders and
      beneficial owners of Registrable Securities are advised to consult their own
      securities law counsel regarding the consequences of being named or not being
      named as a selling securityholder in the Registration Statement and the related
      prospectus.

    

    

    

    

    NOTICE

    

    The
      undersigned beneficial owner (the “Selling Securityholder”) of Registrable
      Securities hereby elects to include the Registrable Securities owned by it
      and
      listed below in Item 3 (unless otherwise specified under such Item 3) in the
      Registration Statement.

    

    

    

    

    

    

    

    

    QUESTIONNAIRE

    
      
         

      

      
        -15-

        
          

        

      

      
         

      

    

     

    The
      undersigned hereby provides the following information to the Company and
      represents and warrants that such information is accurate:

    

    1.    Name.

    

    
      	 	
              (a)

            	
              Full
                Legal Name of Selling
                Securityholder

            

    

    

    

    

     

    
      	 	
              (b)

            	
              Full
                Legal Name of Registered Holder (if not the same as (a) above) through
                which Registrable Securities Listed in Item 3 below are
                held:

            

    

    

    

    

     

    
      	 	
              (c)

            	
              Full
                Legal Name of Natural Control Person (which means a natural person
                who
                directly you indirectly alone or with others has power to vote or
                dispose
                of the securities covered by the
                questionnaire):

            

    

    

    

    

     

    2.    Address
      for Notices to Selling Securityholder:

    

    

    Telephone:
       

    

    Fax:
       

    

    Contact
      Person:  

    

    

    3.    Beneficial
      Ownership of Registrable Securities:

    

    

    (a)    Type
      and
      Number of Registrable Securities beneficially owned:

    

    

    4.    Broker-Dealer
      Status:

     

    (a)    Are
      you a
      broker-dealer? Yes ... No ...

    

    Note: If
      yes,
      the Commission’s staff has indicated that you should be identified as an
      underwriter in the Registration Statement.

    
      
         

      

      
        -16-

        
          

        

      

      
         

      

    

    (b)    Are
      you
      an affiliate of a broker-dealer? Yes ... No ...

    

    
      	
            	(c)	
              If
                you are an affiliate of a broker-dealer, do you certify that you
                bought
                the Registrable Securities in the ordinary course of business, and
                at the
                time of the purchase of the Registrable Securities to be resold,
                you had
                no agreements or understandings, directly or indirectly, with any
                person
                to distribute the Registrable
                Securities?

            

    

    

    Yes ... No ...

    

    

    5.    Beneficial
      Ownership of Other Securities of the Company Owned by the Selling
      Securityholder.

    

    Except
      as
      set forth below in this Item 5, the undersigned is not the beneficial or
      registered owner of any securities of the Company other than the Registrable
      Securities listed above in Item 3.

    

    

    (a)    Type
      and
      Amount of Other Securities beneficially owned by the Selling
      Securityholder:

    

    

    

    6.    Relationship
      with the Company:

    

    Except
      as
      set forth below, neither the undersigned nor any of its affiliates, officers,
      directors or principal equity holders (owners of 5% of more of the equity
      securities of the undersigned) has held any position or office or has had any
      other material relationship with the Company (or its predecessors or affiliates)
      during the past three years. 

    

    State
      any
      exceptions here:

    

    

    

    
 

    The
      undersigned agrees to promptly notify the Company of any inaccuracies or changes
      in the information provided herein that may occur subsequent to the date hereof
      at any time while the Registration Statement remains effective.

    

    

      
        
           

        

        
          -17-

          
            

          

        

        
           

        

      

    By
      signing below, the undersigned consents to the disclosure of the information
      contained herein in its answers to Items 1 through 6 and the inclusion of such
      information in the Registration Statement and the related prospectus. The
      undersigned understands that such information will be relied upon by the Company
      in connection with the preparation or amendment of the Registration Statement
      and the related prospectus.

     

    IN
      WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice
      and Questionnaire to be executed and delivered either in person or by its duly
      authorized agent.

    

    

    

    

    Dated:
      ________________ Beneficial
      Owner:

    

    

    

    

    By:

      
        

      

    

    Name:

    Title:

    

    

    

    

    PLEASE
      FAX A COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE, AND
      RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO:

    

    

    To: PLASTINUM
      POLYMER TECHNOLOGIES CORP. 

    245
      Park
      Avenue, 39th
      Floor

    New
      York,
      NY 10167 

    USA

    Tel:
      + 1
      212 792 41 04

    Cell:
      +
      41 79 213 39 66

    Fax:
      + 41
      44 274 22 59

     

    
      
         

      

        -18-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]